Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Uterus Leiomyosarcoma”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Testing effectiveness (Phase 2)Study completedNCT00041236
What this trial is testing

Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 39
Not applicableStudy completedNCT00614835
What this trial is testing

Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus

Who this might be right for
Uterine LeiomyosarcomaUterine Cancer
Memorial Sloan Kettering Cancer Center 25
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Not applicableEnded earlyNCT01958580
What this trial is testing

Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery

Who this might be right for
Stage IA Uterine SarcomaStage IB Uterine SarcomaStage IC Uterine Sarcoma+8 more
Albert Einstein College of Medicine 3
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00101127
What this trial is testing

Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00003939
What this trial is testing

Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma

Who this might be right for
Brain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more
European Organisation for Research and Treatment of Cancer - EORTC 132
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT05649956
What this trial is testing

Letrozole in Uterine Leiomyosarcoma

Who this might be right for
Uterine Leiomyosarcoma
GOG Foundation 40
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Testing effectiveness (Phase 2)Study completedNCT00003334
What this trial is testing

Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive Tract

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT00033644
What this trial is testing

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

Who this might be right for
Sarcoma
Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)Active Not RecruitingNCT05432791
What this trial is testing

Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped Working

Who this might be right for
Locally Advanced Uterine Corpus LeiomyosarcomaMetastatic Uterine Corpus LeiomyosarcomaStage III Uterine Corpus Leiomyosarcoma AJCC v8+2 more
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Active Not RecruitingNCT04200443
What this trial is testing

Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma

Who this might be right for
Metastatic LeiomyosarcomaMetastatic Soft Tissue SarcomaStage III Uterine Corpus Leiomyosarcoma AJCC v8+8 more
City of Hope Medical Center 72
Testing effectiveness (Phase 2)Study completedNCT01220609
What this trial is testing

Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

Who this might be right for
Recurrent Uterine Corpus SarcomaUterine Corpus Leiomyosarcoma
National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Early research (Phase 1)Ended earlyNCT06299163
What this trial is testing

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma+10 more
Numab Therapeutics AG 11
Testing effectiveness (Phase 2)Study completedNCT02249702
What this trial is testing

Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma

Who this might be right for
Leiomyosarcoma
Mario Negri Institute for Pharmacological Research 168
Testing effectiveness (Phase 2)Ended earlyNCT02601209
What this trial is testing

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Who this might be right for
High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more
National Cancer Institute (NCI) 151
Load More Results